"We compared several companies to perform our biomarker assays. We chose Artialis for their competitive prices and their ability to start analysis in a very short time.

The team was very responsive and gave us updates throughout the process. Moreover, the work was carried out on time."
Confidential Customer
R&D Associate - Confidential Company
"We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence. 

[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art facility, [and] their knowledge in vivo design protocol (...) I would highly recommend the services of Artialis mainly for their high quality and high involvement. "
Confidential Customer
R&D Project Manager - Confidential Company
"We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration."
Elsa Mével
PhD Candidate - INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)
"Since the biomarker world is very competitive, every work involving new biomarkers should be previously and accurately discussed to tune the interests of the Sponsor with those of Artialis. 

They are on time and flexible [and have] the ability to focus rapidly on the Sponsor requirement. 

[We appreciate the] reliability of data and the open and timely communication. "
Gianfranco Caselli
Director Pharmacology & Toxicology - Rottapharm Biotech (Italy)
 © Artialis - All rights reserved
Cookie Notice - Privacy Policy